Acton Capital Partners
Widenmayerstr. 29, Munich, Bayern, 80538, Germany
Overview
Acton Capital is a leading later-stage venture capital investor with presence in Munich and Vancouver. Since 1999, the Acton team backs startups in the fields of fintech, SaaS, consumer health, mobility & logistics, education or future of work on their way to market leadership. With over two decades of investment experience in tech-enabled business models, the team has invested 700+M EUR in more than 199 companies across five fund generations. Acton Capital invests worldwide, with a strong focus on Europe and North America.
- Total investments
- 67
- Lead investments
- 39
- Investments · 12mo
- 4
- Active investors
- 9
Sector focus
- Financial Services
- FinTech
- SaaS
- Venture Capital
Investment portfolio
- JUPUS
Participated · Series A · Jun 2026
JUPUS has developed what it calls Europe’s first AI secretarial service tailored to law firms, automating tasks such as answering client calls, structuring inquiries, preparing cases and drafting legal documents. The platform is positioned to relieve administrative burdens at small and mid-sized law firms and improve lawyers’ ability to focus on substantive work. In 2025 the company reported strong growth—quadrupling annual recurring revenue, tripling headcount, and more than doubling both its user base and the number of cases processed. More than 2,000 lawyers use JUPUS today and the AI handles over 2,000 new legal cases daily, with the company stating it saves firms more than 70 hours per month. JUPUS plans to continue expanding AI capabilities and deepen adoption across Germany and broader Europe using the new funding. The company emphasizes legal-specific features to meet regulatory, privacy and professional requirements distinct from generic AI models.
- Sêmeia
Led · Equity · Jun 2026
Sêmeia develops MedicWise, a digital medical device and platform for remote monitoring of patients with chronic illnesses, aggregating data from lab analyses, connected medical devices and health reimbursement histories. Founded in 2017 in Toulouse, the company initially focused on nephrology and transplantation and has expanded into pneumology, rheumatology, oncology and mental health. MedicWise is used in more than 500 healthcare establishments to monitor about 35,000 patients. Sêmeia analyzes longitudinal clinical data to detect anomalies or deterioration between consultations and routes alerts to care teams. In 2022 the company raised €8 million and acquired competitor Optim’Care to strengthen its position in chronic kidney disease monitoring. With the new funding, Sêmeia plans to broaden specialty coverage, build AI-driven services to prioritize alerts and anticipate complications, and continue pursuing external growth.
- Eolas Medical
Led · Series A · Jan 2026
Eolas Medical is a clinician-led health-tech company whose web and mobile applications replace outdated hospital intranets and fragmented document stores with a single, searchable source of truth for medical guidelines, policies and medicines information. The platform, already embedded in more than 400 UK clinical sites and adopted by 85% of NHS acute trusts, lets clinicians retrieve approved local guidance up to ten times faster than traditional methods. A newly launched AI-powered search allows staff to ask plain-language questions and receive evidence-backed answers drawn directly from their organisation’s internal resources, further supporting safe, consistent, point-of-care decision-making. Around 60% of doctors work in locum or training roles, so the ability to carry a shared clinical playbook between settings is increasingly valuable as care moves beyond hospital walls. With demand on NHS services continuing to grow, Eolas plans to deepen its AI functionality, expand across the UK and Ireland, and begin international deployment. The company operates from Belfast and London and most recently raised $12 million (£8.9 million) in Series A financing led by Acton Capital to fund these growth initiatives.
- Formalize
Led · Series B · Oct 2025
Formalize is a Copenhagen-based compliance software company founded in 2021 that centralises and automates governance, risk and compliance (GRC) workflows. Its platform supports multiple frameworks, including NIS2, DORA, ISO 27001, GDPR and SOC 2, allowing SMEs to consolidate requirements and respond quickly to regulatory changes. Initially launched as Whistleblower Software, the company has since expanded into broader risk, privacy and data compliance and now serves organisations in more than 80 countries and over 12 languages. Formalize positions automation and AI at the core of its product to simplify compliance while preserving security and local expertise. The firm’s customer base numbers in the thousands of SMEs across Europe who face an increasingly complex regulatory landscape. With €50 million raised to date, the company is financially equipped to scale its offering. Recent funding will be used to open offices and grow local teams in key European markets such as the DACH region and France.
- Stotles
Led · Series A · Jun 2025
Stotles is an AI-powered GovTech SaaS platform that automates and streamlines the government sales lifecycle, from market strategy and pipeline building to tender discovery, qualification, and bid generation. The platform surfaces procurement history, partner networks, and early buying signals to help suppliers target opportunities. Customers named in the coverage include Amazon Business, Salesforce, Vodafone, NEC Software, Palo Alto Networks, and Snowflake. Founded in 2020 and headquartered in London, the company focuses on enabling private-sector suppliers to grow revenue in the public sector. Stotles plans to further develop its AI platform and use insights to expand into the US public sector market. The product positioning is B2G sales enablement with a core emphasis on AI-driven procurement intelligence. Stotles offers a business-to-government (B2G) platform that consolidates public‑sector opportunities and data for commercial teams (sales, marketing, partner & alliance, account management). Its product aims to make government procurement information more accessible and actionable, helping customers such as UiPath, Freshworks, and Workday discover relevant opportunities faster and identify buying signals before tenders or RFPs. The company plans to use its new funding to further develop the product, remove paper-based processes in purchasing, grow the team, and expand into new markets. CEO John Witt positions the B2G market as a $12 trillion backbone of the global economy and says Stotles is focused on streamlining processes that connect business and government. Financially, Stotles completed a $6.5M seed round and has raised a total of $8.3M since August 2019. Stotles is a B2G SaaS platform that aggregates and surfaces public sector tender data to help sales and marketing teams win government contracts. The company says tender data is scattered and larger firms often access market signals earlier; Stotles aims to democratise that intel so smaller businesses can compete. Founded in 2019 and based in London, it spent nine months in private beta and has served customers including Freshworks and UiPath. The startup is now accepting applications for an early access programme as it moves beyond private beta. Investors and advisors have framed the product as a way to modernise government procurement and — in the words of Speedinvest’s Jeroen Arts — potentially save taxpayers billions of euros per year. Financially, Stotles has completed a £1.4 million funding round to support its commercial rollout.